Advanced Biomarker Assessment of Adipose Derived Stem Cells and Fibroblasts in Patients with and without Pelvic Organ Prolapse

Overview

About this study

This study will assess advanced biomarkers in patients with and without vaginal prolapse.  Assessments will be directed at vaginal fibroblasts and adipose derived stem cells (ASC’s). 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients undergoing a vaginal hysterectomy for either a pelvic organ prolapse or a non-prolapse benign condition.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Johnny Yi, M.D.

Closed for enrollment

Contact information:

Fady Khorany C.Ph.T.

(480) 574-1323

Khorany.Fady@mayo.edu

More information

Publications

Publications are currently not available